26.10.2023 • News • EuroAPI • Active Pharmaceutical Ingredients (APIs) • Contract Development And Manufacturing Organizations (CDMO)
EuroAPI Announces New Governance
EuroAPI's Board of Directors decided that Karl Rotthier would step down as CEO, effective October 30, 2023. They initiated the search for a new CEO and appointed Viviane Monges, the current Board Chair, as interim CEO until a permanent successor is found, while she continues her role as Board Chair.
The Board of Directors also appointed Elizabeth Bastoni, Chair of the Nominations and Compensation Committee, as the Independent Lead-Director to oversee the company's governance and engage with shareholders on Board-related matters.
The Board of Directors thanked Karl Rotthier for his contributions to EuroAPI since 2021, notably during EuroAPI’s early days, establishing the Company as a new independent major active pharmaceutical ingredient (API) and contract development and manufacturing organization (CDMO) actor on the market. The Board will continue to support the Group’s transformation in a fast-evolving environment and will actively oversee the execution of the strategic review announced earlier this month.
Viviane Monges, Chair of EuroAPI’s Board of Directors appointed Chief Executive Officer for an interim period, effective October 30, 2023. © EuroAPI
Karl Rotthier to step down as Chief Executive Officer, effective October 30, 2023. © EuroAPI
